Showing results (221-230 of 392) with videos related to

Sort By:
Pageof 40
European Journal of Dermatology : EJD|July 22, 2022
The impact of the first COVID-19 wave on office-based dermatological care in Germany: a focus on diagnosis, therapy and prescription of biologicsImke Nordhorn, Daniela Weiss, Thomas Werfel, et al.
Allergy|November 24, 2019
Is allergy immunotherapy with birch sufficient to treat patients allergic to pollen of tree species of the birch homologous group?Jörg Kleine-Tebbe, Torsten Zuberbier, Thomas Werfel, et al.
Clinical and Translational Allergy|April 10, 2019
Cofactors of wheat-dependent exercise-induced anaphylaxis do not increase highly individual gliadin absorption in healthy volunteersKatharina Anne Scherf, Ann-Christin Lindenau, Luzia Valentini, et al.
Human Vaccines & Immunotherapeutics|May 12, 2017
Component-resolved evaluation of the content of major allergens in therapeutic extracts for specific immunotherapy of honeybee venom allergySimon Blank, Stefanie Etzold, Ulf Darsow, et al.
The Journal of Investigative Dermatology|September 4, 2021
Immunocompromised Patients with Therapy-Refractory Chronic Skin Diseases Show Reactivation of Latent Epstein‒Barr Virus and Cytomegalovirus InfectionPhilipp Speth, Manja Jargosch, Peter Seiringer, et al.
JID Innovations : Skin Science From Molecules to Population Health|August 3, 2023
Inflammatory Cues Direct Skin-Resident Type 1 Innate Lymphoid Cells to Adopt a Psoriasis-Promoting IdentityBeatrix D G Evers, Miriam Hils, Christoph Heuser, et al.
Investigative Ophthalmology & Visual Science|December 27, 2011
The cross-linked biopolymer hyaluronic acid as an artificial vitreous substituteCharlotte Schramm, Martin S Spitzer, Sigrid Henke-Fahle, et al.
Dermatology Practical & Conceptual|May 22, 2025
Scabies Management Outcomes: Identification of Risk Factors for Treatment Success or FailureVanessa Azzolina, Franziska Schauer, Julia Felicitas Pilz, et al.
Life (Basel, Switzerland)|October 27, 2022
A Pair of Prognostic Biomarkers in Triple-Negative Breast Cancer: KLK10 and KLK11 mRNA ExpressionYueyang Liu, Weiwei Gong, Sarah Preis, et al.
Expert Opinion on Therapeutic Targets|August 18, 2018
Kallikrein-related peptidases represent attractive therapeutic targets for ovarian cancerDaniela Loessner, Peter Goettig, Sarah Preis, et al.
Pageof 40